Collegium Pharmaceutical, Inc. is a dynamic, biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system and pain conditions. The firm has spent more than a decade proving that responsible stewardship and bold, science-backed approaches can redefine what treatment looks like in categories too often shaped by complexity and misconceptions. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
423
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Collegium Pharmaceutical Inc market cap is $768.18M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Collegium Pharmaceutical Inc 52 week high is $50.79 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Collegium Pharmaceutical Inc 52 week low is $21.43 as of November 21, 2026.
Collegium Pharmaceutical Inc stock price today is $24.72.
Collegium Pharmaceutical Inc stock price yesterday was $25.21.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Collegium Pharmaceutical Inc's P/E ratio is 24.93.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Collegium Pharmaceutical Inc P/B ratio is 2.5911.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Collegium Pharmaceutical Inc 50-day moving average is $23.25.